LMR Partners’s Aralez Pharmaceuticals Inc. ARLZ Stock Holding History
Bought
Maintained
Sold
Other funds holding ARLZ
PCM
BC
JAM
ECP
AC
TLCM
DM
CAD
HVC
VOAM
LMR Partners's ARLZ Position: Q3 2016 in Review
LMR Partners sold out of Aralez Pharmaceuticals Inc. (ARLZ) in Q3 2016, closing a stake of 43,921 shares — an estimated $145K sold.
LMR Partners first reported a position in ARLZ in Q2 2016 and held it in 1 quarter. The position peaked at $145K in Q2 2016. 83 funds tracked by Wall St. Rank hold ARLZ as of Q3 2016.
- LMR Partners reported no remaining Aralez Pharmaceuticals Inc. position as of Q3 2016 after selling out during the quarter.
- LMR Partners sold 43,921 Aralez Pharmaceuticals Inc. shares in Q3 2016, an estimated $145K.
- LMR Partners first reported a position in Aralez Pharmaceuticals Inc. in Q2 2016 and held it in 1 quarter.
- LMR Partners's Aralez Pharmaceuticals Inc. position peaked at $145K in Q2 2016.
- 83 funds tracked by Wall St. Rank held Aralez Pharmaceuticals Inc. as of Q3 2016.
Based on LMR Partners's 13F filing for Q3 2016, filed 1 Nov 2016.